Flavin Financial Services’s Merck MRK Stock Holding History

Flavin Financial Services’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.42M	Buy	20,133 +301	+2%	+$34.8K	1.63%	23
2025 Q4	$2.09M	Sell	19,832 -1,220	-6%	-$115K	1.43%	27
2025 Q3	$1.77M	Buy	21,052 +4,481	+27%	+$369K	1.26%	30
2025 Q2	$1.31M	Sell	16,571 -975	-6%	-$77.5K	1.27%	30
2025 Q1	$1.57M	Buy	17,546 +860	+5%	+$80.3K	1.45%	29
2024 Q4	$1.66M	Buy	+16,686	New	+$1.72M	1.58%	26

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flavin Financial Services's MRK Position: Q1 2026 in Review

Flavin Financial Services increased its Merck (MRK) stake by 1.5% in Q1 2026, buying an estimated $34.8K and bringing the position to 20,133 shares worth $2.42M. The position accounts for 1.63% of the portfolio, ranked #23.

Flavin Financial Services first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Flavin Financial Services held 20,133 shares of Merck worth $2.42M as of Q1 2026.
Flavin Financial Services bought 301 Merck shares in Q1 2026, an estimated $34.8K.
Merck made up 1.63% of Flavin Financial Services's portfolio in Q1 2026, its #23 holding.
Flavin Financial Services first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Flavin Financial Services's 13F filing for Q1 2026, filed 7 May 2026.